Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takashi Inoue

Showing results (561-570 of 625) with videos related to

Pageof 63
Sort By:
Anticancer Research|October 26, 2022
Initial Experience With Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma: A Real-world Retrospective StudySoichi Takeda, Tadashi Namisaki, Yuki Tsuji, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 25, 2024
[A Case of Pathological Complete Response after Nivolumab Therapy in Unresectable Advanced Gastric Cancer]Rei Ogura, Kazuhiro Migita, Ayumi Nishioka, et al.
European Journal of Pharmacology|September 16, 2006
E3024, 3-but-2-ynyl-5-methyl-2-piperazin-1-yl-3,5-dihydro-4H-imidazo[4,5-d]pyridazin-4-one tosylate, is a novel, selective and competitive dipeptidyl peptidase-IV inhibitorNobuyuki Yasuda, Tadashi Nagakura, Takashi Inoue, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 8, 2014
The "sliding door" technique for closure of abdominal wall defects after rectus abdominis musculocutaneous flap transpositionTakayuki Nakamoto, Fumikazu Koyama, Yasunori Kobata, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|November 4, 2015
The NAFLD Index: A Simple and Accurate Screening Tool for the Prediction of Non-Alcoholic Fatty Liver DiseaseNaohiro Ichino, Keisuke Osakabe, Keiko Sugimoto, et al.
Clinical Lung Cancer|June 9, 2022
Real-world clinical practice for advanced non-small-cell lung cancer in the very elderly: A retrospective multicenter analysisTakahiro Fukushima, Yoshitaka Oyamada, Shinnosuke Ikemura, et al.
Trials|February 13, 2021
Fluorescent cystoscopy-assisted en bloc transurethral resection versus conventional transurethral resection in patients with non-muscle invasive bladder cancer: study protocol of a prospective, open-label, randomized control trial (the FLEBER study)Makito Miyake, Nobutaka Nishimura, Takashi Inoue, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|August 21, 2022
Real-World Investigation on Anticoagulation Management Before and After Catheter Ablation for Atrial Fibrillation in Japan　- Periprocedural and Long-Term OutcomesAkihiko Nogami, Kyoko Soejima, Itsuro Morishima, et al.
In Vivo (Athens, Greece)|October 30, 2025
Marked Increase in Zinc Concentration of Ascitic Fluid After Cell-free and Concentrated Ascites Reinfusion Therapy in Patients With Cirrhotic Refractory Ascites: A Retrospective Observational StudyTadashi Namisaki, Akihiko Shibamoto, Satoshi Iwai, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 8, 2026
Lipopolysaccharide Binding Protein and Soluble Mannose Receptor as Biomarkers for Acute Kidney Injury in CirrhosisHiroyuki Masuda, Tadashi Namisaki, Kosuke Kaji, et al.
Pageof 63

Showing results (561-570 of 625) with videos related to

Sort By:
Pageof 63
Anticancer Research|October 26, 2022
Initial Experience With Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma: A Real-world Retrospective StudySoichi Takeda, Tadashi Namisaki, Yuki Tsuji, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 25, 2024
[A Case of Pathological Complete Response after Nivolumab Therapy in Unresectable Advanced Gastric Cancer]Rei Ogura, Kazuhiro Migita, Ayumi Nishioka, et al.
European Journal of Pharmacology|September 16, 2006
E3024, 3-but-2-ynyl-5-methyl-2-piperazin-1-yl-3,5-dihydro-4H-imidazo[4,5-d]pyridazin-4-one tosylate, is a novel, selective and competitive dipeptidyl peptidase-IV inhibitorNobuyuki Yasuda, Tadashi Nagakura, Takashi Inoue, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 8, 2014
The "sliding door" technique for closure of abdominal wall defects after rectus abdominis musculocutaneous flap transpositionTakayuki Nakamoto, Fumikazu Koyama, Yasunori Kobata, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|November 4, 2015
The NAFLD Index: A Simple and Accurate Screening Tool for the Prediction of Non-Alcoholic Fatty Liver DiseaseNaohiro Ichino, Keisuke Osakabe, Keiko Sugimoto, et al.
Clinical Lung Cancer|June 9, 2022
Real-world clinical practice for advanced non-small-cell lung cancer in the very elderly: A retrospective multicenter analysisTakahiro Fukushima, Yoshitaka Oyamada, Shinnosuke Ikemura, et al.
Trials|February 13, 2021
Fluorescent cystoscopy-assisted en bloc transurethral resection versus conventional transurethral resection in patients with non-muscle invasive bladder cancer: study protocol of a prospective, open-label, randomized control trial (the FLEBER study)Makito Miyake, Nobutaka Nishimura, Takashi Inoue, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|August 21, 2022
Real-World Investigation on Anticoagulation Management Before and After Catheter Ablation for Atrial Fibrillation in Japan　- Periprocedural and Long-Term OutcomesAkihiko Nogami, Kyoko Soejima, Itsuro Morishima, et al.
In Vivo (Athens, Greece)|October 30, 2025
Marked Increase in Zinc Concentration of Ascitic Fluid After Cell-free and Concentrated Ascites Reinfusion Therapy in Patients With Cirrhotic Refractory Ascites: A Retrospective Observational StudyTadashi Namisaki, Akihiko Shibamoto, Satoshi Iwai, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 8, 2026
Lipopolysaccharide Binding Protein and Soluble Mannose Receptor as Biomarkers for Acute Kidney Injury in CirrhosisHiroyuki Masuda, Tadashi Namisaki, Kosuke Kaji, et al.
Pageof 63